Galera Angels

Galera Angels, LLC is a Midwest-based angel investment group formed specifically to fund early-stage biotechnology opportunities and pharmaceutical companies targeting cancer therapy side effects. The specialized syndicate was established primarily to provide dedicated financial backing for Galera Therapeutics, a clinical-stage biopharmaceutical startup developing novel drugs designed to reduce radiation toxicity and enhance overall oncology treatments. Comprising 17 individual members, the targeted investment vehicle draws approximately half of its participant base directly from the established St. Louis Arch Angels network. The group participated in multiple financing rounds for its primary portfolio company, initially co-investing in the seed stage alongside lead institutional partner BioGenerator before continuing its support through subsequent capital raises. Although the exact founding year of the entity remains undisclosed, the organization was spearheaded by prominent regional investor Bob Calcaterra to pool local capital for specialized medical ventures.